Literature DB >> 21054178

Posaconazole for chronic pulmonary aspergillosis: the next strategy against the threat of azole-resistant Aspergillus infection.

Shigeru Kohno, Koichi Izumikawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21054178     DOI： 10.1086/657307

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  4 in total

1.  Antifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki, Japan.

Authors:  Masato Tashiro; Koichi Izumikawa; Asuka Minematsu; Katsuji Hirano; Naoki Iwanaga; Shotaro Ide; Tomo Mihara; Naoki Hosogaya; Takahiro Takazono; Yoshitomo Morinaga; Shigeki Nakamura; Shintaro Kurihara; Yoshifumi Imamura; Taiga Miyazaki; Tomoya Nishino; Misuzu Tsukamoto; Hiroshi Kakeya; Yoshihiro Yamamoto; Katsunori Yanagihara; Akira Yasuoka; Takayoshi Tashiro; Shigeru Kohno
Journal:  Antimicrob Agents Chemother       Date:  2011-10-24       Impact factor: 5.191

2.  Correlation between triazole treatment history and susceptibility in clinically isolated Aspergillus fumigatus.

Authors:  Masato Tashiro; Koichi Izumikawa; Katsuji Hirano; Shotaro Ide; Tomo Mihara; Naoki Hosogaya; Takahiro Takazono; Yoshitomo Morinaga; Shigeki Nakamura; Shintaro Kurihara; Yoshifumi Imamura; Taiga Miyazaki; Tomoya Nishino; Misuzu Tsukamoto; Hiroshi Kakeya; Yoshihiro Yamamoto; Katsunori Yanagihara; Akira Yasuoka; Takayoshi Tashiro; Shigeru Kohno
Journal:  Antimicrob Agents Chemother       Date:  2012-07-02       Impact factor: 5.191

Review 3.  [Aspergillus in airway material : Ignore or treat?]

Authors:  H J F Salzer; C Lange; M Hönigl
Journal:  Internist (Berl)       Date:  2017-11       Impact factor: 0.743

4.  Triazole phenotypes and genotypic characterization of clinical Aspergillus fumigatus isolates in China.

Authors:  Shuwen Deng; Lili Zhang; Yanfeng Ji; Paul E Verweij; Kin Ming Tsui; Ferry Hagen; Jos Houbraken; Jacque F Meis; Parida Abliz; Xiaodong Wang; Jingjun Zhao; Wanqing Liao
Journal:  Emerg Microbes Infect       Date:  2017-12-06       Impact factor: 7.163
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.